Stocks-ADVM-Adverum Biotechnologies Inc

ADVM Adverum Biotechnologies Inc

0.6599 -0.0001 (-0.02%)
Invest
Invest

Overview

Prev Close0.6599
Day's Range 0.6210 - 0.6400
52 Week Range 0.6100 - 1.96
Average Volume (3m)502.01K
1-Year Return-63.81%
Beta1.158
Market Cap65.81M
P/E Ratio
Revenue0
EPS-1.5802
Dividend (Yield)0 (0%)
1 Day 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years Max
Chart times in UTC
Industry Pharmaceuticals Major
CEO Laurent Fischer, MD
Employees 188

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2021: Adverum Biotechnologies Inc's revenues increased by ∞% and amounted to 7.50M. Net income decreased by 23.86% to -145.54M. Net assets decreased by 27.20% to 316.19M and EPS decreased from -1.38 to -1.48.
ADVM's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
36.76%
Net Profit Margin
-7,055.39%
Operating Margin
N/A
Return On Investment
-31.73%
12/21
03/22
06/22
09/22
Total Revenue
0
0
0
0
Gross Profit
-1.32M
-1.43M
-1.6M
-1.79M
Operating Income
-34.43M
-38.13M
-42.01M
N/A
Net Income
-34.41M
-37.91M
-43.76M
-40.13M